Rehabilitation of Edentulous Area With an Implant Level Set-upNCT02789956
Internal vs. External Connection in Screw-retained Multi-units Bridges With Cad/Cam Milled Co/Cr Framework (ISUS-Atlantis)
A study testing Internal vs. external cad cam co/cr framework in people with Rehabilitation of Edentulous Area With an Implant Level Set-up, run by Institute Franci at 1 site in Italy.
Trial summary
The aim of this study is to evaluate: Primary objective The primary objective of the present study is to evaluate the marginal bone level changes when partially edentulous patients, treated with implants, received a multiunits screw retained fixed dental prosthesis with a Co/Cr milled framework with an Internal or… Read more about this study
- Who is it for?
- Ages 18 to 90 yearsHealthy volunteers can take part
- Conditions the study is for
- Rehabilitation of Edentulous Area With an Implant Level Set-up
- What is being tested?
- Internal vs. external cad cam co/cr framework
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 48 participants
- Where
- 1 siteItaly
- Study dates
- Jul 2016to Sep 2025
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 90 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Age > 18 years.
- Willingness to comply with all study requirements and to sign the IC.
- Systemic health.
- Compliance with good oral hygiene.
- Patients with at least 2 teeth to replace in any side of the jaws.
Who cannot join
- Patients treated with implant with bone defects associated with severe knife-edge ridges.
- Patients treated with bone defects resulting from tumor resection.
- Tobacco abuse (> 10 cigarettes/day).
- Severe renal and liver disease.
- History of radiotherapy in the head and neck region.
- Chemotherapy for treatment of malignant tumors at the time of the surgical procedure.
Show all 12Show fewer
- Uncontrolled diabetes.
- Active periodontal disease involving the residual opposite dentition.
- Mucosal disease, such as lichen planus, in the areas to be treated.
- Poor oral hygiene.
- Non-compliant patients.
- Situations judged inconvenient(by the investigator) for the surgical treatment.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Clinical Outcomes of Implant- Versus Abutment-level Connection in Screw-retained Fixed Dental Prostheses
The aim of this study is to evaluate:
Primary objective The primary objective of the present study is to evaluate the marginal bone level changes when partially edentulous patients, treated with implants, received a multiunits screw retained fixed dental prosthesis with a Co/Cr milled framework with an Internal or External connection.
Secondary objective
- Overall survival rate.
- Soft tissue status by assessment of bleeding on probing (BoP) and probing pocket depth (PPD) at baseline and after 1,3,5 years.
- Prosthetic survival rates including screw or abutment loosening, framework or veneer fractures.
Read the detailed description
A randomized pilot study is designed to determine marginal bone changes between patients treated with a milled framework in Co/Cr if the connection is Internal or External for the rehabilitation of a partially edentulous area with a multiunit screw retained bridge. The investigation will be performed in one clinical centre affiliated to the Department of oral and maxillofacial surgery, Faculty of Odontology, Malmö University . In this center the clinician and the examiner will be the same person.
Following a screening examination, subjects who will meet the inclusion criteria, will sign the Informed Consent and will be enrolled in the study. The period of patient enrollment will begin on October 1st 2015 and ends September 31st 2016.
The patients will be randomized with a method based on the use of sealed opaque envelopes. The cases will be assigned to two different treatment groups:
Group A- Co/Cr milled framework with internal connection (Test) Group B- Co/Cr milled framework with external connection (Control)
-Pre-treatment Patient data, medical history, clinical and radiographic examination will be recorded for each patient. Clinical photographs will be taken in frontal, occlusal and lateral projections Periodontal, endodontic and open caries lesions will be treated prior to implant installation. All patients will receive careful oral hygiene instructions and training in self-performed plaque control measure.
Orthopantomogram at constant magnification and CT scan computed exams will be carried out.
Plaster models and diagnostic wax-up will be carried out.
-First Surgical Phase (Implant Installation) The patient will receive antibiotic prophylaxis (Amoxicillin 1gr) one hour prior to surgery and after the completion of implant installation until suture removal with 1gr three times a day. (If the patient is allergic to amoxicillin the examiner prescribes antibiotics at his own discretion at the same posology).
The surgical treatment will be performed under local anaesthesia. In case of remaining teeth, they will be extracted with conventional technique before implants' placement.
Implants will be placed according to the guidelines described in the Astra Tech Osseospeed EV® manual "Surgical procedures", using a two-stage protocol.
Implant spinning during the positioning of the cover screw will be registered as positive, if present, or negative.
The operation will be finalized by a careful adaption of the flaps by means of an accurate suture in order to obtain a full periosteal coverage.
Intraoral clinical photographs before, during and after surgery will be taken. -Post-operative care The patients will be instructed to rinse with chlorhexidine 0.12% mouthrinse and will be told to rinse with the antiseptic solution three times a day for 2 weeks. The patients will be advised to take NSAIDs for pain relief at their own discretion.
Liquid and semisolid food will be prescribed for the first post-operative week, after which the sutures will be removed.
Two weeks after the operation the denture will be properly relined until the second stage surgery.
Patients will be controlled at third and sixth weeks.
-Prosthetic procedures After eight weeks (+ 2) of implants healing a second stage surgery will be applied and Healing Abutment will be performed groups A while a Uni Abutment 33° connection procedure will be performed. In group B.
Impression with a customized spoon and Impregum material will be taken after one week from the second surgery and prosthetic procedure will be performed according to the Atlantis-Isus Dentsply Astra-tech prosthetic manual recommendations.
After 6 weeks (+ 2) from impression the definitive fixed dental prostheses screw retained multiunits bridge will be applied.
The prosthesis will be made to accomplish the normal hygienic procedures. All prosthetic procedures will be made in accordance to the Astra Tech procedures \& products manuals.
The length of bridge cantilevers will be duly calculated to minimize implant overloading according to the Atlantis-Isus recommendations for both group.
-Post-prosthetic measurements Clinical measurements Clinical examinations will be performed immediately following the installation of the definitive prosthesis (Baseline-Loading) and after 1, 3, and 5 years. In particular, plaque and soft-tissue inflammation will be registered. Clinical photographs will be taken at each interval point.
Plaque: the presence of plaque will be scored at each implant site as well as at level of the remaining teeth on four surfaces (buccal, lingual/palatal, mesial, distal). The mean percentage of plaque harboring surfaces will be calculated using the case as the unit.
Soft-tissue inflammation: the presence of soft-tissue inflammation (bleeding on probing) will be assessed on buccal, lingual/palatal, mesial, distal aspects of each implant. The mean percentage of inflamed sites will be calculated using the case as the unit.
- Radiographic measurements
Peri-apical radiographs will be taken at prosthesis insertion (Baseline) and after 1, 3, and 5 years.
The radiographs will be taken with an X-ray apparatus supplied with a long cone by the examiner each visiting time. Rinn centrators will be used to ensure reproducibility in the measurement of marginal bone level change.
The radiographic images will be analysed at the Department of Radiology of Sahlgrenska Academy, Gothenburg University by experienced radiologists who will be otherwise not involved in the study.
- STATISTICAL ANALYSIS
Results will be presented by appropriate descriptive and inferential statistic. Demographic and other baseline characteristics will be presented by means of descriptive statistics. Continuous variables will be presented by means of number of observations (N), minimum (min), median, maximum (max), mean and standard deviation (std). Discrete variables will be presented by frequency and percentage.
- Being tested
- Internal vs. external cad cam co/cr framework
- Keywords
- Internal connection, Cobalt/Chrome, Cad-cam Framework, marginal bone level
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Internal vs. external cad cam co/cr frameworkDevice
Also called Astratech EV system, Dentsply HI
| Study group | Role | What they receive |
|---|---|---|
| Test: internal connection | Experimental | Evaluate marginal bone level (MBL) changes at implants that are placed semi-edentulous patient when they are treated with implant level Co/cr Cad/Cam framework. Receives: Device: Internal vs. external cad cam co/cr framework |
| Test: external connection | Active comparator | Evaluate marginal bone level (MBL) changes at implants that are placed semi-edentulous patient when they are treated with abutment level Co/cr Cad/Cam framework. Receives: Device: Internal vs. external cad cam co/cr framework |
What is being measured
The primary outcome is the main question the study is designed to answer.
Marginal bone resorption in millimeter from the implant to the bone crest.
Measured: 1 year
Marginal bone resorption in millimeter from the implant to the bone crest.
Measured: 3 year
Marginal bone resorption in millimeter from the implant to the bone crest.
Measured: 5 year
Secondary outcomes (3)
Fracture of the prosthetic components
Measured: 1 year
Fracture of the prosthetic components
Measured: 3 year
Fracture of the prosthetic components
Measured: 5 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Jun 2016 (estimated)
- Study startJul 2016
- Primary completionSep 2024
- Study completionSep 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Rehabilitation of Edentulous Area With an Implant Level Set-upStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 48 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Institute Franci
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Toia Marco, Malmö University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02789956
- Sponsor's protocol ID
- IIS-14-083
- Status last verified
- Feb 2025
- First submitted
- 29 May 2016
- Last updated
- 5 Feb 2025
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 5 Feb 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Clinical Outcomes of Implant- Versus Abutment-level Connection in Screw-retained Fixed Dental Prostheses
- ClinicalTrials.gov ID
- NCT02789956
- Acronym / sponsor ID
- IIS-14-083
- Keywords
- Internal connection, Cobalt/Chrome, Cad-cam Framework, marginal bone level
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 48 participants (estimated)
- Lead sponsor
- Institute FranciUniversity, hospital or other
- Study start
- Jul 2016 (actual)
- Primary completion
- Sep 2024 (actual)
- Study completion
- Sep 2025 (estimated)
- First posted
- 3 Jun 2016 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this study is to evaluate:
Primary objective The primary objective of the present study is to evaluate the marginal bone level changes when partially edentulous patients, treated with implants, received a multiunits screw retained fixed dental prosthesis with a Co/Cr milled framework with an Internal or External connection.
Secondary objective
- Overall survival rate.
- Soft tissue status by assessment of bleeding on probing (BoP) and probing pocket depth (PPD) at baseline and after 1,3,5 years.
- Prosthetic survival rates including screw or abutment loosening, framework or veneer fractures.
Detailed description
A randomized pilot study is designed to determine marginal bone changes between patients treated with a milled framework in Co/Cr if the connection is Internal or External for the rehabilitation of a partially edentulous area with a multiunit screw retained bridge. The investigation will be performed in one clinical centre affiliated to the Department of oral and maxillofacial surgery, Faculty of Odontology, Malmö University . In this center the clinician and the examiner will be the same person.
Following a screening examination, subjects who will meet the inclusion criteria, will sign the Informed Consent and will be enrolled in the study. The period of patient enrollment will begin on October 1st 2015 and ends September 31st 2016.
The patients will be randomized with a method based on the use of sealed opaque envelopes. The cases will be assigned to two different treatment groups:
Group A- Co/Cr milled framework with internal connection (Test) Group B- Co/Cr milled framework with external connection (Control)
-Pre-treatment Patient data, medical history, clinical and radiographic examination will be recorded for each patient. Clinical photographs will be taken in frontal, occlusal and lateral projections Periodontal, endodontic and open caries lesions will be treated prior to implant installation. All patients will receive careful oral hygiene instructions and training in self-performed plaque control measure.
Orthopantomogram at constant magnification and CT scan computed exams will be carried out.
Plaster models and diagnostic wax-up will be carried out.
-First Surgical Phase (Implant Installation) The patient will receive antibiotic prophylaxis (Amoxicillin 1gr) one hour prior to surgery and after the completion of implant installation until suture removal with 1gr three times a day. (If the patient is allergic to amoxicillin the examiner prescribes antibiotics at his own discretion at the same posology).
The surgical treatment will be performed under local anaesthesia. In case of remaining teeth, they will be extracted with conventional technique before implants' placement.
Implants will be placed according to the guidelines described in the Astra Tech Osseospeed EV® manual "Surgical procedures", using a two-stage protocol.
Implant spinning during the positioning of the cover screw will be registered as positive, if present, or negative.
The operation will be finalized by a careful adaption of the flaps by means of an accurate suture in order to obtain a full periosteal coverage.
Intraoral clinical photographs before, during and after surgery will be taken. -Post-operative care The patients will be instructed to rinse with chlorhexidine 0.12% mouthrinse and will be told to rinse with the antiseptic solution three times a day for 2 weeks. The patients will be advised to take NSAIDs for pain relief at their own discretion.
Liquid and semisolid food will be prescribed for the first post-operative week, after which the sutures will be removed.
Two weeks after the operation the denture will be properly relined until the second stage surgery.
Patients will be controlled at third and sixth weeks.
-Prosthetic procedures After eight weeks (+ 2) of implants healing a second stage surgery will be applied and Healing Abutment will be performed groups A while a Uni Abutment 33° connection procedure will be performed. In group B.
Impression with a customized spoon and Impregum material will be taken after one week from the second surgery and prosthetic procedure will be performed according to the Atlantis-Isus Dentsply Astra-tech prosthetic manual recommendations.
After 6 weeks (+ 2) from impression the definitive fixed dental prostheses screw retained multiunits bridge will be applied.
The prosthesis will be made to accomplish the normal hygienic procedures. All prosthetic procedures will be made in accordance to the Astra Tech procedures \& products manuals.
The length of bridge cantilevers will be duly calculated to minimize implant overloading according to the Atlantis-Isus recommendations for both group.
-Post-prosthetic measurements Clinical measurements Clinical examinations will be performed immediately following the installation of the definitive prosthesis (Baseline-Loading) and after 1, 3, and 5 years. In particular, plaque and soft-tissue inflammation will be registered. Clinical photographs will be taken at each interval point.
Plaque: the presence of plaque will be scored at each implant site as well as at level of the remaining teeth on four surfaces (buccal, lingual/palatal, mesial, distal). The mean percentage of plaque harboring surfaces will be calculated using the case as the unit.
Soft-tissue inflammation: the presence of soft-tissue inflammation (bleeding on probing) will be assessed on buccal, lingual/palatal, mesial, distal aspects of each implant. The mean percentage of inflamed sites will be calculated using the case as the unit.
- Radiographic measurements
Peri-apical radiographs will be taken at prosthesis insertion (Baseline) and after 1, 3, and 5 years.
The radiographs will be taken with an X-ray apparatus supplied with a long cone by the examiner each visiting time. Rinn centrators will be used to ensure reproducibility in the measurement of marginal bone level change.
The radiographic images will be analysed at the Department of Radiology of Sahlgrenska Academy, Gothenburg University by experienced radiologists who will be otherwise not involved in the study.
- STATISTICAL ANALYSIS
Results will be presented by appropriate descriptive and inferential statistic. Demographic and other baseline characteristics will be presented by means of descriptive statistics. Continuous variables will be presented by means of number of observations (N), minimum (min), median, maximum (max), mean and standard deviation (std). Discrete variables will be presented by frequency and percentage.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Test: internal connection | Experimental | Device: Internal vs. external cad cam co/cr frameworkEvaluate marginal bone level (MBL) changes at implants that are placed semi-edentulous patient when they are treated with implant level Co/cr Cad/Cam framework. |
| Test: external connection | Active comparator | Device: Internal vs. external cad cam co/cr frameworkEvaluate marginal bone level (MBL) changes at implants that are placed semi-edentulous patient when they are treated with abutment level Co/cr Cad/Cam framework. |
Who may qualify
- Ages
- 18 to 90 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Age > 18 years.
- Willingness to comply with all study requirements and to sign the IC.
- Systemic health.
- Compliance with good oral hygiene.
- Patients with at least 2 teeth to replace in any side of the jaws.
Key exclusion criteria (12 listed)
- Patients treated with implant with bone defects associated with severe knife-edge ridges.
- Patients treated with bone defects resulting from tumor resection.
- Tobacco abuse (> 10 cigarettes/day).
- Severe renal and liver disease.
- History of radiotherapy in the head and neck region.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Internal vs. external cad cam co/cr frameworkAlso: Astratech EV system, Dentsply HI | Device | Test: external connection, Test: internal connection |
Primary outcome
Marginal bone resorption in millimeter from the implant to the bone crest.
Time frame: 1 year
Marginal bone resorption in millimeter from the implant to the bone crest.
Time frame: 3 year
Marginal bone resorption in millimeter from the implant to the bone crest.
Time frame: 5 year
3 secondary outcomes
Fracture of the prosthetic components
Time frame: 1 year
Fracture of the prosthetic components
Time frame: 3 year
Fracture of the prosthetic components
Time frame: 5 year
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Feb 2025.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Internal vs. external cad cam co/cr framework in people with Rehabilitation of Edentulous Area With an Implant Level Set-up, run by Institute Franci at 1 site in Italy.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 5 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Marginal bone resorption in millimeter from the implant to the bone crest. (time frame: 1 year). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Feb 2025.